Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. May 21, 2025; 31(19): 105283
Published online May 21, 2025. doi: 10.3748/wjg.v31.i19.105283
Table 1 Baseline characteristics of patients with and without anastomotic leakage, n (%)

NAL (n = 1732)
AL (n = 86)
P value
Sex = male1055 (60.9)64 (74.4)0.016
Tobacco or alcohol< 0.001
    No1256 (72.5)46 (53.5)
    Tobacco258 (14.9)18 (20.9)
    Alcohol25 (1.4)1 (1.2)
    All193 (11.1)21 (24.4)
T stage< 0.001
    T1192 (11.1)2 (2.3)
    T2453 (26.2)17 (19.8)
    T3995 (57.4)43 (50.0)
    T492 (5.3)24 (27.9)
N stage0.025
    N0291 (16.8)12 (14.0)
    N11260 (72.7)57 (66.3)
    N2181 (10.5)17 (19.8)
Histological type< 0.001
    Adenocarcinoma36 (2.1)0 (0.0)
    Adenosquamouscarcinoma0 (0.0)6 (7.0)
    Others1663 (96.0)80 (93.0)
    Multi1 (0.1)0 (0.0)
    Neuroendocrine17 (1.0)0 (0.0)
    Stromal15 (0.9)0 (0.0)
Family = yes32 (1.8)10 (11.6)< 0.001
CD34 = yes647 (37.4)67 (77.9)< 0.001
FOBT = M11276 (73.7)64 (74.4)0.978
Location = others76 (4.4)2 (2.3)0.517
Age = high871 (50.3)39 (45.3)0.433
Neoadjuvant = yes142 (8.2)57 (66.3)< 0.001
Table 2 Evaluation indicators in testing set of 10 machine learning models
Model
Accuracy
Sensitivity/PPV
Specificity/NPV
F1
Logistic.R0.9160.980.9120.521
SVM.R0.8730.760.8790.355
GBM.R0.9010.960.8980.471
NeuralNetwork.R0.890.980.8850.455
RandomForest.R0.9740.560.9940.667
XGBoost.R0.9250.920.9270.708
KNN.R0.9190.880.9210.5
Adaboost.R0.9030.80.9080.43
LightGBM.R0.9160.920.9150.5
CatBoost.R0.9060.960.9040.485
Logistic.S0.9140.980.910.515
SVM.S0.9520.920.9540.639
GBM.S0.9560.960.9560.667
NeuralNetwork.S0.9580.960.9580.676
RandomForest.S0.950.760.960.585
XGBoost.S0.9390.960.9380.593
KNN.S0.9520.840.9580.618
Adaboost.S0.8040.920.7980.301
LightGBM.S0.9270.960.9250.545
CatBoost.S0.9430.960.9420.608